ProMIS director receives new stock option grants
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ProMIS Neurosciences Inc. director Eugene Williams reported receiving two option grants to buy common shares. On May 20, 2026, he was awarded options for 11,000 shares and 5,500 shares, each with an exercise price of $10.77 per share and expiring on May 20, 2036.
According to the footnotes, the 11,000-share option vests in full on May 20, 2027, subject to his continued service on the board. For the 5,500-share option, 25% vested upon grant and the remaining shares vest ratably over 36 months, also conditioned on continued board service. These are compensation-related awards, not open‑market purchases.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option (right to buy) | 5,500 | $0.00 | $0.00 |
| Grant/Award | Option (right to buy) | 11,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. The shares subject to this option shall vest in full on May 20, 2027, subject to continued service on the Board.
- F2. 25% of the shares subject to this option vested upon grant with the remaining shares vesting ratably over thirty-six months, subject to continued service on the Board.
Key Figures
Key Terms
Option (right to buy) financial
grant/award acquisition financial
vest in full financial
vesting ratably over thirty-six months financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ProMIS Neurosciences (PMN) report for Eugene Williams?
How many ProMIS Neurosciences (PMN) options did Eugene Williams receive?
What is the exercise price of Eugene Williams’s ProMIS (PMN) stock options?
When do Eugene Williams’s ProMIS Neurosciences (PMN) options vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.